The Department of Defense is hosting the Joint Medical Acquisition Talks (JMAT) in July 2026, aimed at briefing the industrial base on acquisition issues and potential opportunities within the medical supply chain. This event is a special notice, not a contract opportunity, and is suitable for small businesses interested in the medical equipment sector under NAICS 339112. Attendees should note that while there is no fee for the event, all associated costs, including lodging, are the responsibility of the attendee, and registration is required to secure a spot.
Analysis by Mindy, grounded in the SAM.gov notice.
Description
This is NOT a contract opportunity. This is an announcement for an upcoming conference.
DLA Troop Support’s Medical supply chain is hosting the first Joint Medical Acquisition Talks (JMAT) in July 2026. The Capital Equipment Division, Defense Health Agency, and other partners will brief the industrial base on current acquisition issues and potential business opportunities within the Division’s product lines.
There is no fee for the event but all costs of attending, including lodging costs (whether within the room block or not), are solely the responsibility of the attendee.
The event will be held at the DoubleTree by Hilton located at 2349 Marlton Pike West (Rt. 70W) in Cherry Hill, NJ 08002 on July 14-15, 2026. Each individual attending is required to register at the following link: https://forms.osi.apps.mil/r/1pSfdZFEEy. After submitting your registration, an automated email will be sent with details regarding reservations within the event’s room block, provided you indicate that lodging is required in your registration.
Event registrations will close when attendance limits are met. Room block reservations will close 6/29/2026 at 5PM Eastern Time, or earlier if inventory is completely booked. The tentative agenda is attached.
Source: SAM.gov, as posted. Verify the current solicitation before responding.
Pursue this opportunity with Mindy
See who holds it now, who else is bidding, and draft your response — grounded in real government data, not generic AI.